Literature DB >> 12710684

Genetic alterations in esophageal cancer.

Jun-ichi Okano1, Lorraine Snyder, Anil K Rustgi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12710684     DOI： 10.1385/1-59259-328-3:131

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  16 in total

1.  Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion.

Authors:  Katharine D Grugan; Charles G Miller; Yao Yao; Carmen Z Michaylira; Shinya Ohashi; Andres J Klein-Szanto; J Alan Diehl; Meenhard Herlyn; May Han; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus.

Authors:  Ling Yang; Li-Shu Wang; Xiaoxin Luke Chen; Zoran Gatalica; Suimin Qiu; Zhihua Liu; Gary Stoner; Hongwei Zhang; Heidi Weiss; Jingwu Xie
Journal:  Int J Biochem Mol Biol       Date:  2012-02-10

Review 3.  Cancer.

Authors:  Adda Grimberg
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

4.  PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.

Authors:  Yan Li; Nilesh Chitnis; Hiroshi Nakagawa; Yoshiaki Kita; Shoji Natsugoe; Yi Yang; Zihai Li; Mariusz Wasik; Andres J P Klein-Szanto; Anil K Rustgi; J Alan Diehl
Journal:  Cancer Discov       Date:  2015-01-12       Impact factor: 39.397

5.  AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture.

Authors:  K Oyama; T Okawa; H Nakagawa; M Takaoka; C D Andl; S-H Kim; A Klein-Szanto; J A Diehl; M Herlyn; W El-Deiry; A K Rustgi
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

6.  Photoimmunotherapy for cancer-associated fibroblasts targeting fibroblast activation protein in human esophageal squamous cell carcinoma.

Authors:  Shinichiro Watanabe; Kazuhiro Noma; Toshiaki Ohara; Hajime Kashima; Hiroaki Sato; Takuya Kato; Shinichi Urano; Ryoichi Katsube; Yuuri Hashimoto; Hiroshi Tazawa; Shunsuke Kagawa; Yasuhiro Shirakawa; Hisataka Kobayashi; Toshiyoshi Fujiwara
Journal:  Cancer Biol Ther       Date:  2019-06-11       Impact factor: 4.742

7.  A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion.

Authors:  Katharine D Grugan; Maria E Vega; Gabrielle S Wong; J Alan Diehl; Adam J Bass; Kwok K Wong; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Cancer Biol Ther       Date:  2013-06-18       Impact factor: 4.742

8.  p120-catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma.

Authors:  Heather L Lehman; Xuebin Yang; Patricia A Welsh; Douglas B Stairs
Journal:  Am J Pathol       Date:  2015-01       Impact factor: 4.307

Review 9.  Inhibiting PI3K as a therapeutic strategy against cancer.

Authors:  Luis Paz-Ares; Carmen Blanco-Aparicio; Rocío García-Carbonero; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

10.  Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.

Authors:  Carmen Blanco-Aparicio; Marta Cañamero; Yolanda Cecilia; Belén Pequeño; Oliver Renner; Irene Ferrer; Amancio Carnero
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.